Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
Diverticular Disease of the Colon01:27

Diverticular Disease of the Colon

Diverticular disease involves the formation of diverticula—small sac-like outpouchings of the colonic wall—and their complications. It most commonly affects the sigmoid colon due to higher intraluminal pressure and structural vulnerability. It results from structural weakness and increased pressure in the colon, producing pseudodiverticula that may remain silent or progress to inflammation and serious complications.Structure of DiverticulaIn diverticulosis, these outpouchings are...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to multi-target stool DNA colorectal cancer screening among Medicare patients in Alabama.

Current medical research and opinion·2026
Same author

Multitarget Stool DNA Versus Fecal Immunochemical Testing: A National Assessment of Follow-Up Colonoscopy by Race and Ethnicity.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Outcomes and Characteristics Across Age Groups of Patients with Positive MT-sDNA Stool Tests: Data from the New Hampshire Colonoscopy Registry.

Digestive diseases and sciences·2026
Same author

Real-World Completion of Multitarget Stool DNA Testing Among Texas Medicare Beneficiaries: Associations With Payer Type, Digital Outreach, and Social Vulnerability.

Journal of health economics and outcomes research·2026
Same author

Authors' reply.

Annals of gastroenterology·2026
Same author

Adherence to Obstetrician-/Gynecologist-Ordered Multi-target Stool DNA Test Screening and Follow-Up Colonoscopy: A National Multi-payer Study of US Women.

Advances in therapy·2026

Related Experiment Video

Updated: Jun 26, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Screening Among Veterans and Civilians Enrolled in

Michael Fuchs1,2, Shrey Gohil3, Jordan J Karlitz3

  • 1Central Virginia VA Health Care System, Richmond, VA 23249, United States.

Military Medicine
|June 24, 2026
PubMed
Summary

Adherence to multi-target stool DNA (mt-sDNA) colorectal cancer screening was 72.4% among Veterans Health Administration enrollees. Higher income and opting into digital notifications improved adherence, supporting mt-sDNA integration in VHA screening programs.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

DNA Viral Size Fraction Metagenomics for Human Stool Samples
05:15

DNA Viral Size Fraction Metagenomics for Human Stool Samples

Published on: March 24, 2026

Related Experiment Videos

Last Updated: Jun 26, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

DNA Viral Size Fraction Metagenomics for Human Stool Samples
05:15

DNA Viral Size Fraction Metagenomics for Human Stool Samples

Published on: March 24, 2026

Area of Science:

  • Oncology
  • Gastroenterology
  • Public Health

Background:

  • Non-invasive colorectal cancer screening relies on stool-based testing.
  • Multi-target stool DNA (mt-sDNA) tests show higher completion rates than other stool tests.
  • Limited data exist on mt-sDNA test adherence among Veterans Health Administration (VHA) enrollees.

Purpose of the Study:

  • To assess mt-sDNA test adherence among VHA enrollees.
  • To identify factors associated with mt-sDNA test adherence in this population.

Main Methods:

  • Retrospective study of adults aged 45-75 prescribed mt-sDNA testing via VHA insurance.
  • Data sourced from Abbott database (August 2022-January 2026).
  • Kaplan-Meier, log-rank, and logistic regression analyses used to evaluate adherence and associated factors.

Main Results:

  • Overall adherence was 72.4% (6,234/8,613); median time to adherence was 16 days.
  • Lower adherence linked to metropolitan residence (aOR=0.78).
  • Higher adherence associated with income ≥$125k (aOR=1.49), prescription by OB/GYN (aOR=1.45), and digital notifications (aOR=2.02).

Conclusions:

  • VHA enrollee adherence to mt-sDNA testing exceeds previously reported rates.
  • Findings support integrating mt-sDNA testing into VHA colorectal cancer screening.
  • Future research should examine follow-up colonoscopy adherence to optimize screening.